CRP and myeloid sarcoma: Inflammatory markers such as CRP, neutrophils, and the neutrophil-to-lymphocyte ratio (NLR) were significantly elevated in the patients from the PSO–MS subgroup, compared to patients from the PSO subgroup (p < 0.001).